Edition:
United Kingdom

TSO3 Inc (TOS.TO)

TOS.TO on Toronto Stock Exchange

0.92CAD
24 Apr 2018
Change (% chg)

$0.01 (+1.10%)
Prev Close
$0.91
Open
$0.92
Day's High
$0.92
Day's Low
$0.90
Volume
23,174
Avg. Vol
207,793
52-wk High
$3.30
52-wk Low
$0.90

Latest Key Developments (Source: Significant Developments)

TSO3 Provides Duodenoscope Regulatory Filing Update
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - TSO3 Inc ::TSO3 PROVIDES DUODENOSCOPE REGULATORY FILING UPDATE.TSO3 - DIALOGUE WITH U.S. REGULATORS IN CONNECTION WITH REQUEST FOR AI REGARDING CO'S SUBMISSION TO EXTEND CLAIMS OF STERIZONE VP4 STERILIZER.TSO3 SAYS NEXT WRITTEN EXCHANGE WITH U.S. REGULATORS IS PLANNED PRIOR TO END OF YEAR, AFTER WHICH ANOTHER DISCUSSION WILL BE SCHEDULED IN EARLY 2018.  Full Article

TSO3 provides duodenoscope regulatory filing update
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - TSO3 Inc :TSO3 provides duodenoscope regulatory filing update.TSO3-Responded to request for additional information from U.S. FDA; information is in support of submission to extend claims of Sterizone VP4 sterilizer​.  Full Article

TSO3 reports record third quarter 2017 results
Tuesday, 7 Nov 2017 

Nov 6 (Reuters) - TSO3 Inc :TSO3 reports record third quarter 2017 results.TSO3 Inc-qtrly ‍revenue increased to $5.1 million, an 11% sequential increase over $4.6 million recorded in Q2 of 2017​.Qtrly loss per share $0.02‍​.  Full Article

TSO3 reports Q2 loss per share $0.02
Wednesday, 3 Aug 2016 

TSO3 Inc : Q2 loss per share $0.02 .Revenues were $3.0 million in Q2 2016 versus $3.1 million in Q1 2016 and $0.1 million in Q2 2015..  Full Article

TSO3 responds to U.S. FDA on extended claims, gives operations update
Wednesday, 1 Jun 2016 

Tso3 Inc : TSO3 responds to u.s. Regulators on extended claims and provides operations update . Responded to a previously announced request for additional information by U.S. Food and Drug Administration . Co's response allows FDA to continue their review for market clearance on extended claims for sterizone VP4 sterilizer in U.S. . Production and operational improvements co made on assembly facility had a minimal impact on Q2 2016 production . Substantially completed its improvements to its manufacturing facility in Québec .Operational improvements to its assembly facility are designed to increase assembly capacity and efficiency.  Full Article

BRIEF-TSO3 Reports Qtrly ‍Loss Per Share​ of $0.02

* QTRLY ‍REVENUES INCREASED TO $5.8 MILLION, AS COMPARED TO $5.1 MILLION IN Q3 OF 2017 AND $3.7 MILLION IN Q4 OF 2016​